Felix Forster
YOU?
Author Swipe
View article: Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison Open
Background Measuring specific anti-SARS-CoV-2 antibodies has become one of the main epidemiological tools to survey the ongoing SARS-CoV-2 pandemic, but also vaccination response. The WHO made available a set of well-characterized samples …
View article: The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant Open
View article: Socioeconomic and risk-related drivers of compliance with measures to prevent SARS-CoV-2 infection: evidence from the Munich-based KoCo19 study
Socioeconomic and risk-related drivers of compliance with measures to prevent SARS-CoV-2 infection: evidence from the Munich-based KoCo19 study Open
View article: The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 – Results from a prospective cohort of outpatient COVID-19 cases
The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 – Results from a prospective cohort of outpatient COVID-19 cases Open
View article: From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany) Open
View article: Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich - One year of experience
Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich - One year of experience Open
View article: In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients
In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients Open
Our findings suggest both quantitative anti-S1 assays (EI-S1-IgG-quant and Ro-RBD-Ig-quant) may replace direct neutralization assays in quantitative measurement of immune protection against SARS-CoV-2 in certain circumstances. However, alt…
View article: From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)
From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany) Open
Background In the 2 nd year of the Covid-19 pandemic, knowledge about the dynamics of the infection in the general population is still limited. Such information is essential for health planners, as many of those infected show no or only mi…
View article: Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich Open
Given the large number of mild or asymptomatic SARS-CoV-2 cases, only population-based studies can provide reliable estimates of the magnitude of the pandemic. We therefore aimed to assess the sero-prevalence of SARS-CoV-2 in the Munich ge…
View article: Publisher Correction to: Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)
Publisher Correction to: Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19) Open
View article: Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)
Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19) Open
View article: Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)
Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19) Open
Background The SARS-CoV-2 pandemic is leading to the global introduction of public health interventions to prevent the spread of the virus and avoid the overload of health care systems, especially for the most severely affected patients. S…
View article: Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich Open
View article: Competition Damages Actions
Competition Damages Actions Open
The paper discusses the proposed damages directive of the European Commission and the draft that has been adopted by the European Parliament and the Council on the 17th of April 2014 and is now with the EU Council of Ministers for final ap…